"The project has the potential to significantly improve the health and well-being of older people with subclinical hypothyroidism"
- Professor David Stott from the University of Glasgow
TRUST Thyroid trial

What will happen to the results of the research study?

The results of the main part of the research should be available within 6 months of you completing the study, and it is expected the primary publication will be within 12 months.

You and your GP will be informed in writing of the key results of the study (anticipated between 6 and 12 months after you finishing in the study), and also which group you were in (thyroxine or placebo capsules). The results and details of publications will also be placed on the study website, at the time of publication. You will not be identified in any report or publication.

Who is organising and funding the research?

The organisation funding the research is the European Union. The team conducting the research in Scotland is from the University of Glasgow (linking with Greater Glasgow Health Board); this research is in collaboration with Leiden University Medical Centre in the Netherlands, Cork in Ireland, and University of Berne in Switzerland. We are also collaborating with thyroid experts from the University of California in the USA.

Who has reviewed the study?

The research project has been reviewed by, and received approval from the following;
  • The European Union grant reviewers (includes ethical review).
  • The Scottish Multicentre Research Ethics Committee (MREC A).
  • Thyroid Federation International, the umbrella organisation for patient support groups for those with thyroid disorders. It aims to work for the benefit of those affected by thyroid disorders throughout Europe and the world.

PUBLICATIONS and documents

Subclinical thyroid disorders. (The Lancet)